Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment.
Marc-Nicolas RentinckRenate KrügerPia-Alice HoppeDaniel HummeMichaela NiebankAnna PokrywkaMiriam Songa StegemannAxel KolaLeif Gunnar HanitschRasmus LeistnerPublished in: PloS one (2021)
Our data shows that outpatient decolonization offers a highly cost-effective secondary prevention strategy, which may prevent costly inpatient treatments. Therefore, health insurance companies should consider providing coverage of outpatient treatment of recurrent PVL-SA skin and soft tissue infections.